Rezolute says late-stage trial data for lead asset remains under FDA review

Story context

What to watch: Monitor chip inventory cycles — overhang periods precede sharp upside moves in semis.

Latest session change: $RZLT -9.09%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures come from the published headline or preview. Session moves may include other news and do not establish cause.